• Tina Utech, Jens Köhler, Helmut Buschmann, Jörg Holenz, Jose Miguel Vela, and Bernhard Wünsch.
• Institut für Pharmazeutische und Medizinische Chemie, Münster, Germany.
• Arch. Pharm. (Weinheim). 2011 Jul 1;344(7):415-21.

AbstractBased on the pharmacophore model of Glennon the conformationally restricted σ(1) receptor ligand 2 with a 1,3-dioxane moiety has been designed and synthesized. The three step synthesis (transacetalization with pentane-1,3,5-triol, tosylation, and nucleophilic substitution with benzylamine) provided diastereoselectively the cis-configured 1,3-dioxane 2 in good yields. The 1,3-dioxane 2 represents a potent σ(1) receptor ligand (K(i) = 19 nM) with moderate selectivity over the σ(2) subtype (K(i) = 92 nM) and excellent selectivity against more than 60 other targets. Additionally the hERG K(+) channel is not affected by 2. In the capsaicin assay 2 showed extraordinarily high analgesic activity with more than 70% analgesia at the very low dose of 0.25 mg/kg body weight, which indicates σ(1) antagonistic activity. Since 2 does only interact with σ(1) receptors, the in-vivo antiallodynic activity of 2 must be attributed to the σ(1) antagonistic activity.Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

27 keywords...

hide…